New steroids and new salicylates in inflammatory bowel disease: a critical appraisal
M Campieri, M Campieri
Abstract
Although new salicylates are now available for the treatment of ulcerative colitis, sulphasazaline still has an important therapeutic role. The role of salicylates in Crohn's disease is limited to the mild activity phase; further data are required to clarify its role in maintenance on remission. New steroids are a real alternative to traditional steroids in active ulcerative colitis and Crohn's disease.
References
- Gastroenterology. 1998 Jan;114(1):15-22
- Am J Gastroenterol. 1997 Oct;92(10):1867-71
- N Engl J Med. 1998 Aug 6;339(6):370-4
- Aliment Pharmacol Ther. 1998 Apr;12(4):361-6
- Aliment Pharmacol Ther. 1998 Dec;12(12):1207-16
- Gastroenterology. 1999 Feb;116(2):294-300
- Gastroenterology. 2000 Feb;118(2):264-73
- Am J Gastroenterol. 2000 May;95(5):1263-76
- Am J Gastroenterol. 2000 Jul;95(7):1628-36
- Gastroenterology. 2000 Aug;119(2):597
- Gut. 2001 Feb;48(2):186-90
- Lancet. 1977 Oct 29;2(8044):892-5
- Gastroenterology. 1979 Oct;77(4 Pt 2):847-69
- Gastroenterology. 1984 Feb;86(2):249-66
- Dis Colon Rectum. 1986 Feb;29(2):108-10
- J Clin Gastroenterol. 1988 Aug;10(4):406-9
- Dis Colon Rectum. 1989 May;32(5):398-9
- Gastroenterology. 1990 Apr;98(4):811-8
- Gut. 1991 Aug;32(8):929-31
- Gastroenterology. 1993 Feb;104(2):435-9
- Gut. 1994 Mar;35(3):360-2
- Aliment Pharmacol Ther. 1993 Dec;7(6):611-6
- Aliment Pharmacol Ther. 1994 Feb;8(1):35-43
- N Engl J Med. 1994 Sep 29;331(13):836-41
- N Engl J Med. 1994 Sep 29;331(13):842-5
- Aliment Pharmacol Ther. 1994 Aug;8(4):465-8
- Gastroenterology. 1995 Feb;108(2):345-9
- Gastroenterology. 1995 Aug;109(2):404-13
- Aliment Pharmacol Ther. 1995 Jun;9(3):293-300
- Gastroenterology. 1996 Jan;110(1):45-51
- Eur J Gastroenterol Hepatol. 1996 Jun;8(6):549-53
- Gut. 1996 Jul;39(1):82-6
- Gastroenterology. 1997 Apr;112(4):1069-77
- Gut. 1997 Jun;40(6):775-81
- Gut. 1997 Aug;41(2):209-14
- Dis Colon Rectum. 1998 Jan;41(1):93-7
Source: PubMed